ASH Group Meetings

Saturday, December 7th

9:00 AM PT (12:00 PM ET) - Marc Braunstein

• Multiple Myeloma, Lymphoma | Co-Director of Hematology-Oncology, NYU Grossman Long Island School of Medicine, NYU Langone Hospitals

9:00 AM PT (12:00 PM ET) - Christine Duncan

• Sickle Cell | Associate Professor of Pediatrics, Harvard Medical School

10:00 AM PT (1:00 PM ET) - Ravi Vij

• Multiple Myeloma | Professor of Medicine in Hematology-Oncology and Bone Marrow Transplantation, Washington University School of Medicine in St. Louis, MyCancerHaven

10:00 AM PT (1:00 PM ET) - Ben Samelson-Jones

• Hemophilia | Assistant Professor of Pediatrics, University of Pennsylvania

11:00 AM PT (2:00 PM ET) - Andrew Yee

• Multiple Myeloma | Clinical Director, Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School

11:00 AM PT (2:00 PM ET) - Kevin Kuo

• Hemoglobinopathies | Associate Professor, Faculty of Medicine, University of Toronto

12:00 PM PT (3:00 PM ET) - Joshua Brody

• Lymphoma | Associate Professor, Division of Hematology and Oncology, Icahn School of Medicine, Mount Sinai

12:00 PM PT (3:00 PM ET) - David Sallman

• AML/MDS | Associate Member and Myeloid Section Head, H. Lee Moffitt Cancer Center and Research Institute

1:00 PM PT (4:00 PM ET) - Sagar Patel

• Leukemias, Lymphoma | Assistant Professor, Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah

1:00 PM PT (4:00 PM ET) - Nirmish Shah

• Sickle Cell | Assistant Professor of Medicine and Pediatrics, Duke University

2:00 PM PT (5:00 PM ET) - Andrew Branagan

• Multiple Myeloma, Lymphoma | Medical Director, Mass General Cancer Center at Nantucket Cottage Hospital

3:00 PM PT (6:00 PM ET) - Michael Grunwald

• Cell Therapy, MPNs, AML/MDS, GVHD | Chief of the Leukemia Division and Director of Transplantation and Cellular Therapy Program, Levine Cancer Institute at Atrium Health

Sunday, December 8th

9:00 AM PT (12:00 PM ET) - Farhad Ravandi

• Leukemias | Professor of Medicine, The University of Texas MD Anderson Cancer Center

9:00 AM PT (12:00 PM ET) - Ashwin Kishtagari

• MPNs (Myelofibrosis, PV, ET), AML/MDS | Assistant Professor of Medicine in Hematology and Oncology, Vanderbilt University Medical Center

10:00 AM PT (1:00 PM ET) - Ran Reshef

• Cell Therapy | Professor of Medicine and Director of the Cellular Immunotherapy Program, Columbia University Medical Center

11:00 AM PT (2:00 PM ET) - Jae Park

• Cell Therapy, Leukemia | Chief of Cellular Therapy Service, Memorial Sloan Kettering Cancer Center

11:00 AM PT (2:00 PM ET) - William Matsui

• Hematologic Malignancy | Deputy Director, Livestrong Foundation Inc.

12:00 PM PT (3:00 PM ET) - Justin Kaner

• Leukemia, MDS, MPN | Assistant Professor of Clinical Medicine, Leukemia Program, Weill Cornell Medicine

12:00 PM PT (3:00 PM ET) - Susanna Curtis

• Sickle Cell | Assistant Director of the Sickle Cell Program, Icahn School of Medicine, Mount Sinai

1:00 PM PT (4:00 PM ET) - Andrew Kuykendall

• MPN (Myelofibrosis, PV, ET, SM) | Assistant Member in Malignant Hematology, Moffitt Cancer Center, USF Health

1:00 PM PT (4:00 PM ET) - David Vesole

• Multiple Myeloma | Director, Myeloma Program; Professor of Medicine, MedStar Georgetown University Hospital

2:00 PM PT (5:00 PM ET) - Binod Dhakal

• Multiple Myeloma | Associate Professor of Medicine, Medical College of Wisconsin

2:00 PM PT (5:00 PM ET) - Thomas Leblanc

• Leukemia, MDS, MPNs | Associate Professor of Medicine, Duke University School of Medicine, Duke Cancer Institute

3:00 PM PT (6:00 PM ET) - Sunil Iyer

• Leukemia, MDS, Myelofibrosis, PV, ET | Assistant Professor of Medicine, Columbia University Medical Center

3:00 PM PT (6:00 PM ET) - Jeffrey Wolf

• Multiple Myeloma | Staff Physician, The University of California, San Francisco

Monday, December 9th

9:00 AM PT (12:00 PM ET) - Douglas Tremblay

• MPNs (Myelofibrosis, PV, ET), AML, CML | Physician and Assistant Professor of Hematology-Oncology, Icahn School of Medicine, Mount Sinai

9:00 AM PT (12:00 PM ET) - Joshua Sasine

• CAR T's | Assistant Professor of Medicine and Founder & Co-Director of the CAR-T Program, Cedars-Sinai Medical Center

10:00 AM PT (1:00 PM ET) - Beverly Schaefer

• Hemophilia | Assistant Professor of Oncology, Roswell Park Comprehensive Cancer Center

10:00 AM PT (1:00 PM ET) - Elias Jabbour

• AML, CML, ALL, MDS | Associate Professor, The University of Texas M. D. Anderson Cancer Center

11:00 AM PT (2:00 PM ET) - Rory Shallis

• Leukemia, MDS, MPN | Assistant Professor of Medicine in Hematology and Member of the Developmental Therapeutics Research Program, Yale University

11:00 AM PT (2:00 PM ET) - Sherif Badawy

• Non-Malignant Hematology | Founder and Chief Executive Officer, Dar Baklava

12:00 PM PT (3:00 PM ET) - Marco Davila

• CAR-T's | Vice Chair for Cellular Therapies, Roswell Park Cancer Institute

12:00 PM PT (3:00 PM ET) - Ryan Jacobs

• CLL, Lymphoma | Director of Lymphoma, Associate Professor, Levine Cancer Institute

1:00 PM PT (4:00 PM ET) - Marco Ruella

• Multiple Myeloma | Attending Physician, Scientific Director, Assistant Professor, University of Pennsylvania

2:00 PM PT (5:00 PM ET) - Saurabh Dahiya

• CAR-T's | Associate Professor of Medicine and Clinical Director of Cancer Cell Therapy, Stanford University School of Medicine